Atlas Trials

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)

Clinical trial NCT00500682 · COMPLETED

Trial details

NCT number
NCT00500682
Sponsor
Tanabe Pharma Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2007-07-01
Primary completion
2011-10-01
Enrollment
1020

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.